[PHARMA] YoY TTM Result on 30-Jun-2012 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
08-Aug-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Jun-2012 [#2]
Profit Trend
QoQ- 2.74%
YoY- 87.92%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Revenue 2,113,938 2,002,411 1,846,836 1,642,700 1,492,216 1,321,763 1,289,459 8.58%
PBT 126,467 109,249 79,270 102,587 53,876 69,675 86,658 6.49%
Tax -26,277 -41,209 -29,878 -34,308 -17,749 -17,335 -24,472 1.19%
NP 100,190 68,040 49,392 68,279 36,127 52,340 62,186 8.26%
-
NP to SH 99,663 66,756 47,949 67,151 35,734 52,027 60,598 8.64%
-
Tax Rate 20.78% 37.72% 37.69% 33.44% 32.94% 24.88% 28.24% -
Total Cost 2,013,748 1,934,371 1,797,444 1,574,421 1,456,089 1,269,423 1,227,273 8.59%
-
Net Worth 528,477 502,293 480,568 481,394 451,517 417,065 400,161 4.74%
Dividend
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Div 88,011 44,519 41,172 52,948 - 118,755 57,770 7.26%
Div Payout % 88.31% 66.69% 85.87% 78.85% - 228.26% 95.33% -
Equity
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Net Worth 528,477 502,293 480,568 481,394 451,517 417,065 400,161 4.74%
NOSH 259,057 258,914 258,370 117,700 106,994 106,939 106,995 15.87%
Ratio Analysis
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
NP Margin 4.74% 3.40% 2.67% 4.16% 2.42% 3.96% 4.82% -
ROE 18.86% 13.29% 9.98% 13.95% 7.91% 12.47% 15.14% -
Per Share
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
RPS 816.01 773.39 714.80 1,395.66 1,394.66 1,235.99 1,205.16 -6.28%
EPS 38.47 25.78 18.56 57.05 33.40 48.65 56.64 -6.24%
DPS 34.00 17.20 15.94 44.99 0.00 111.00 54.00 -7.41%
NAPS 2.04 1.94 1.86 4.09 4.22 3.90 3.74 -9.60%
Adjusted Per Share Value based on latest NOSH - 117,700
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
RPS 146.68 138.94 128.14 113.98 103.54 91.71 89.47 8.58%
EPS 6.92 4.63 3.33 4.66 2.48 3.61 4.20 8.67%
DPS 6.11 3.09 2.86 3.67 0.00 8.24 4.01 7.26%
NAPS 0.3667 0.3485 0.3334 0.334 0.3133 0.2894 0.2777 4.74%
Price Multiplier on Financial Quarter End Date
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Date 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 30/06/10 30/06/09 -
Price 7.13 4.61 4.49 10.18 5.90 4.98 3.80 -
P/RPS 0.87 0.60 0.63 0.73 0.42 0.40 0.32 18.13%
P/EPS 18.53 17.88 24.19 17.84 17.67 10.24 6.71 18.43%
EY 5.40 5.59 4.13 5.60 5.66 9.77 14.90 -15.55%
DY 4.77 3.73 3.55 4.42 0.00 22.29 14.21 -16.62%
P/NAPS 3.50 2.38 2.41 2.49 1.40 1.28 1.02 22.80%
Price Multiplier on Announcement Date
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Date 17/08/15 21/08/14 16/08/13 08/08/12 10/08/11 11/08/10 21/08/09 -
Price 5.65 4.62 4.66 8.83 5.90 4.95 4.00 -
P/RPS 0.69 0.60 0.65 0.63 0.42 0.40 0.33 13.07%
P/EPS 14.69 17.92 25.11 15.48 17.67 10.17 7.06 12.98%
EY 6.81 5.58 3.98 6.46 5.66 9.83 14.16 -11.48%
DY 6.02 3.72 3.42 5.09 0.00 22.42 13.50 -12.58%
P/NAPS 2.77 2.38 2.51 2.16 1.40 1.27 1.07 17.17%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment